TMIST, NCT03233191: Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer |
|
|
| Recruiting | 3 | 128905 | Europe, Canada, US, RoW | Digital Mammography, Full Field Digital Mammography, FFDM, Digital Tomosynthesis Mammography, DBT, Digital Breast Tomosynthesis, Digital Tomosynthesis of the Breast, Laboratory Biomarker Analysis, Biomarker analysis, genetic analysis, PAM50 | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Canadian Cancer Trials Group (CCTG) | Breast Screening | 12/30 | 12/30 | | |
NCT05754749: Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
|
|
| Recruiting | 1 | 20 | US | Iohexol 350 Mg/mL Injectable Solution, Contrast- enhanced digital breast tomosynthesis (CE-DBT) | UNC Lineberger Comprehensive Cancer Center | Breast Cancer | 08/25 | 08/25 | | |
